RPG Life Sciences Limited — Updates, 29-07-2026: General Updates
29-07-2026 | 11:44 pm
29-07-2026 | 11:44 pm
RPGLIFE transferred its API business (95.06 Cr revenue) to subsidiary RPGAP for ~33.55 Cr. RPGAP secured 243.33 Cr from investors for ~40% stake, aiming for 700 Cr API growth, and will acquire Actis Generics (FY25 turnover 48.25 Cr) for 80 Cr.